Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
5.45
+0.71 (14.98%)
At close: Dec 5, 2025, 4:00 PM EST
5.95
+0.50 (9.17%)
After-hours: Dec 5, 2025, 7:57 PM EST
Pomdoctor Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | 366.86 | 342.56 | 304.85 | 245.22 | 215.38 | 141.21 | Upgrade
|
| Revenue Growth (YoY) | 12.13% | 12.37% | 24.32% | 13.85% | 52.53% | -23.89% | Upgrade
|
| Cost of Revenue | 315.19 | 294.86 | 266.13 | 190.36 | 162.88 | 87.48 | Upgrade
|
| Gross Profit | 51.67 | 47.69 | 38.72 | 54.86 | 52.51 | 53.72 | Upgrade
|
| Selling, General & Admin | 74.78 | 68.24 | 55.99 | 54.87 | 102.95 | 292.16 | Upgrade
|
| Research & Development | 2.97 | 3 | 3.37 | 3.59 | 4.28 | 1.99 | Upgrade
|
| Operating Expenses | 77.75 | 71.25 | 59.36 | 58.46 | 107.23 | 294.14 | Upgrade
|
| Operating Income | -26.08 | -23.55 | -20.64 | -3.59 | -54.73 | -240.42 | Upgrade
|
| Interest Expense | -13.26 | -12.96 | -13.85 | -16.02 | -16.29 | -14 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.38 | 1.39 | -0.85 | -0.21 | -0.22 | -1.47 | Upgrade
|
| EBT Excluding Unusual Items | -38.96 | -35.13 | -35.34 | -19.83 | -71.24 | -255.88 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.5 | - | - | - | Upgrade
|
| Asset Writedown | -4.26 | -2.24 | -1.11 | - | -24.94 | - | Upgrade
|
| Other Unusual Items | -105.68 | -105.97 | -108.44 | -105.68 | -92.24 | -0.6 | Upgrade
|
| Pretax Income | -148.9 | -143.34 | -145.39 | -125.51 | -188.42 | -256.48 | Upgrade
|
| Earnings From Continuing Operations | -148.9 | -143.34 | -145.39 | -125.51 | -188.42 | -256.48 | Upgrade
|
| Minority Interest in Earnings | 0 | -0.03 | -0 | 0 | 0.02 | 0.04 | Upgrade
|
| Net Income | -148.9 | -143.36 | -145.39 | -125.51 | -188.4 | -256.44 | Upgrade
|
| Net Income to Common | -148.9 | -143.36 | -145.39 | -125.51 | -188.4 | -256.44 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 38 | 38 | 24 | 24 | 103 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 38 | 38 | 24 | 24 | 103 | Upgrade
|
| Shares Change (YoY) | 56.11% | - | 56.11% | - | -76.35% | - | Upgrade
|
| EPS (Basic) | -3.93 | -3.79 | -3.84 | -5.18 | -7.77 | -2.50 | Upgrade
|
| EPS (Diluted) | -3.93 | -3.79 | -3.84 | -5.18 | -7.77 | -2.50 | Upgrade
|
| Free Cash Flow | -20.51 | -16.17 | -45.91 | -22.02 | -15.68 | -34.8 | Upgrade
|
| Free Cash Flow Per Share | -0.54 | -0.43 | -1.21 | -0.91 | -0.65 | -0.34 | Upgrade
|
| Gross Margin | 14.08% | 13.92% | 12.70% | 22.37% | 24.38% | 38.05% | Upgrade
|
| Operating Margin | -7.11% | -6.88% | -6.77% | -1.47% | -25.41% | -170.26% | Upgrade
|
| Profit Margin | -40.59% | -41.85% | -47.69% | -51.18% | -87.47% | -181.61% | Upgrade
|
| Free Cash Flow Margin | -5.59% | -4.72% | -15.06% | -8.98% | -7.28% | -24.64% | Upgrade
|
| EBITDA | -25.95 | -23.42 | -20.53 | 14.08 | -37.05 | -221.86 | Upgrade
|
| EBITDA Margin | -7.07% | -6.84% | -6.73% | 5.74% | -17.20% | -157.12% | Upgrade
|
| D&A For EBITDA | 0.13 | 0.13 | 0.11 | 17.68 | 17.68 | 18.56 | Upgrade
|
| EBIT | -26.08 | -23.55 | -20.64 | -3.59 | -54.73 | -240.42 | Upgrade
|
| EBIT Margin | -7.11% | -6.88% | -6.77% | -1.47% | -25.41% | -170.26% | Upgrade
|
| Revenue as Reported | 366.86 | 342.56 | 304.85 | 245.22 | - | - | Upgrade
|
| Advertising Expenses | - | 11.1 | 3.43 | 1.37 | 7.29 | 215 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.